Mustang Bio, Inc.

NasdaqCM:MBIO Stock Report

Market Cap: US$5.6m

Mustang Bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:MBIO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Dec 25SellUS$4Adam ChillIndividual4US$0.95
30 Dec 25BuyUS$238David JinIndividual247US$0.96
30 Dec 25SellUS$238Neil HerskowitzIndividual247US$0.96

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MBIO?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders3,4670.0458%
Public Companies535,5777.07%
Institutions1,483,72319.6%
General Public5,554,01873.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 73.1%.

Top Shareholders

Top 25 shareholders own 26.7% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.2%
City Of Hope
845,385US$627.3k0%100.0%
7.07%
Fortress Biotech, Inc.
535,577US$397.4k108%no data
2.32%
Kestra Advisory Services, LLC
176,042US$130.6k58.5%no data
1.71%
Armistice Capital LLC
129,213US$95.9k0%no data
1.22%
Geode Capital Management, LLC
92,790US$68.9k187%no data
1.12%
BlackRock, Inc.
84,745US$62.9k0%no data
0.7%
Citadel Advisors LLC
53,200US$39.5k-37.2%no data
0.42%
Vanguard Fiduciary Trust Company
32,120US$23.8k0%no data
0.34%
Vanguard Capital Management, LLC
25,704US$19.1k0%no data
0.27%
CFO4Life Group, LLC
20,461US$15.2k57.9%no data
0.22%
Two Sigma Investments, LP
16,754US$12.4k-58.2%no data
0.048%
UBS Asset Management AG
3,659US$2.7k8,220%no data
0.025%
Tower Research Capital Europe Limited
1,895US$1.4k102%no data
0.021%
Manuel Litchman
1,615US$1.2k3.33%no data
0.012%
Antecedo Asset Management GmbH
933US$692.10%no data
0.0067%
SBI Holdings, Inc.
509US$377.8-74.7%no data
0.005%
Michael Zelefsky
379US$281.10%no data
0.005%
Adam Chill
375US$278.30%no data
0.0045%
Lindsay Rosenwald
342US$253.60%no data
0.0043%
Michael Weiss
325US$241.20%no data
0.0038%
David Jin
286US$211.90%no data
0.0021%
Nomura Investment Management Business Trust
160US$118.60%no data
0.0019%
Neil Herskowitz
145US$107.40%no data
0.0016%
Morgan Stanley
118US$87.7-22.9%no data
0.00017%
Frost Investment Advisors, LLC
13US$9.60%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/10 23:51
End of Day Share Price 2026/06/10 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mustang Bio, Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mayank MamtaniB. Riley Securities, Inc.
Justin ZelinB. Riley Securities, Inc.
Joseph PantginisH.C. Wainwright & Co.